Structural basis for the regulation of maternal embryonic leucine zipper kinase

Area of Science:

• Biochemistry
• Molecular Biology
• Structural Biology

Background:

• Maternal embryonic leucine zipper kinase (MELK) is an AMP-activated protein kinase (AMPK)-related kinase implicated in various cellular processes.
• MELK is recognized as a promising therapeutic target for specific cancer types.
• The precise regulatory mechanisms governing MELK activity remain largely unelucidated.

Purpose of the Study:

• To elucidate the structural basis for MELK regulation.
• To investigate the molecular mechanisms underlying MELK activation and catalytic activity.
• To provide a foundation for the development of targeted MELK inhibitors for cancer therapy.

Main Methods:

• X-ray crystallography to determine the structure of a human MELK fragment (kinase and UBA domains).
• Biochemical assays to analyze MELK activity and its dependence on reducing agents.
• Structural analysis to understand domain interactions and activation segment conformation.

Main Results:

• The crystal structure reveals the ubiquitin-associated (UBA) domain interacting with the kinase domain, potentially stabilizing its conformation and activity.
• A unique intramolecular disulfide bond was identified within the kinase domain's activation segment.
• Structural and biochemical data elucidate the autophosphorylation/activation mechanism and the requirement for reducing agents for MELK catalytic activity.

Conclusions:

• The UBA domain's interaction with the kinase domain is crucial for MELK conformation and function.
• The unique disulfide bond and dependence on reducing agents offer novel insights into MELK regulation.
• These findings provide critical structural and mechanistic information for designing targeted MELK inhibitors for cancer treatment.